Treatment of Opioid Use Disorder in Young Adults Hospitalized with Infectious Complications of Injection Opioid Use
因注射阿片类药物使用引起感染性并发症而住院的年轻人阿片类药物使用障碍的治疗
基本信息
- 批准号:10834850
- 负责人:
- 金额:$ 18.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY/ABSTRACT
Young adults have rising rates of opioid-related morbidity and mortality, and those who inject opioids are a
particularly vulnerable group. Infectious bacterial complications of injection drug use (IC-IDU) contribute to high
morbidity and mortality and lead to lengthy hospitalizations for severe infections, such as endocarditis and
osteomyelitis. Despite evidence showing receipt of medications for opioid use disorder (MOUD) can reduce
opioid-related mortality and that initiation of MOUD during hospitalization leads to improved engagement in
OUD treatment at discharge, only a minority of patients receive MOUD during hospitalization. Untreated
substance use in young adults hospitalized with IC-IDU leads to readmissions, high medical costs, and
recurrent infections. As a health services researcher and specialty-trained physician in adolescent and
addiction medicine, I am well trained to identify the health needs of this population and to not only design
effective interventions, but to translate them into clinical practice.
The overall objective of this application is to develop a clinician-facing intervention to improve delivery of
MOUD to hospitalized young adults with IC-IDU. Specific aims include: 1a) Identify multi-level barriers and
facilitators that may influence the delivery of MOUD during hospitalization, by conducting semi-structured
qualitative interviews with the following stakeholders: clinicians, hospital social workers/case managers, and
young adults. 1b) Use intervention mapping to systematically develop a clinician-facing intervention. We will
build on components of an existing outpatient intervention to develop a multi-component, inpatient clinician-
facing intervention to improve delivery of MOUD. 2) Pilot test a clinician-facing intervention to improve delivery
of MOUD. The intervention will focus on changing clinician behavior and addressing key patient, provider and
system-level barriers to improve hospital prescription of MOUD and linkage to outpatient OUD treatment. Our
primary outcomes will include feasibility and acceptability.
An acceptable and feasible health system intervention to improve delivery of MOUD to young adults with OUD
and IC-IDU would address a profound public health crisis. Our aims will identify best practices for recruitment
and retention, support development and testing of study measures, and identify potential difficulties in delivery
of the intervention bundle. This will lead to a R01 hybrid effectiveness-implementation trial to test the impact of
the intervention and supportive implementation strategies in multiple clinical sites. This award will allow me to
become an independent clinician-investigator in health services research and implementation science.
项目总结/摘要
年轻人与阿片类药物有关的发病率和死亡率不断上升,注射阿片类药物的人是一个危险的群体。
尤其是弱势群体。注射药物使用的感染性细菌并发症(IC-IDU)导致
发病率和死亡率,并导致长期住院治疗严重感染,如心内膜炎,
骨髓炎尽管有证据表明接受阿片类药物使用障碍(MOUD)的药物治疗可以减少
阿片类药物相关死亡率和住院期间MOUD的启动导致参与改善,
出院时接受OUD治疗,只有少数患者在住院期间接受MOUD治疗。未处理
因IC-IDU住院的年轻人使用药物导致再次入院,医疗费用高,
反复感染。作为一名青少年健康服务研究人员和受过专门训练的医生,
成瘾医学,我训练有素,以确定这一人群的健康需求,不仅设计
有效的干预措施,而是将其转化为临床实践。
该应用程序的总体目标是开发一种面向临床医生的干预措施,以改善
MOUD适用于IC-IDU住院的年轻成人。具体目标包括:1a)确定多层次的障碍,
可能影响住院期间MOUD交付的促进者,通过进行半结构化的
与以下利益相关者进行定性访谈:临床医生,医院社会工作者/病例管理者,以及
年轻人1b)使用干预映射系统地开发面向临床医生的干预。我们将
建立在现有门诊干预的组成部分,以发展多组成部分,住院临床医生-
面临干预,以改善MOUD的交付。2)试点测试面向临床医生的干预措施,以改善分娩
的MOUD。干预措施将侧重于改变临床医生的行为,并解决关键患者、提供者和
改善MOUD的医院处方和与门诊OUD治疗的联系的系统级障碍。我们
主要结果将包括可行性和可接受性。
一种可接受且可行的卫生系统干预措施,以改善向患有OUD的年轻人提供MOUD
IC-IDU将解决一场深刻的公共卫生危机。我们的目标是确定招聘的最佳做法
和保留,支持研究措施的开发和测试,并确定交付中的潜在困难
的干预措施。这将导致进行R 01混合动力有效性实施试验,以测试
在多个临床站点的干预和支持性实施策略。这个奖项将让我
成为卫生服务研究和实施科学的独立临床研究员。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inpatient Addiction Medicine Consultation Service Impact on Post-discharge Patient Mortality: a Propensity-Matched Analysis.
住院成瘾医学咨询服务对出院后患者死亡率的影响:倾向匹配分析。
- DOI:10.1007/s11606-021-07362-8
- 发表时间:2022
- 期刊:
- 影响因子:5.7
- 作者:Wilson,JDeanna;AltieriDunn,StefanieC;Roy,Payel;Joseph,Emily;Klipp,Stephanie;Liebschutz,Jane
- 通讯作者:Liebschutz,Jane
Racial Diversity Among American Cardiologists: Implications for the Past, Present, and Future.
- DOI:10.1161/circulationaha.121.053566
- 发表时间:2021-06-15
- 期刊:
- 影响因子:37.8
- 作者:Johnson, Amber E.;Talabi, Mehret Birru;Bonifacino, Eliana;Culyba, Alison J.;Davis, Esa M.;Davis, Paula K.;De Castro, Laura M.;Essien, Utibe R.;Gonzaga, Alda Maria;Hogan, MaCalus, V;James, Alaina J.;Jonassaint, Charles R.;Jonassaint, Naudia L.;Matheo, Loreta;Nance, Melonie A.;Napoe, G. Sarah;Olafiranye, Oladipupo;Owusu-Ansah, Sylvia;Pierson-Brown, Tomar N.;Smith, A. J. Conrad;Suber, Tomeka L.;Torres, Orquidia;Tripp, Rickquel;Ufomata, Eloho;Wilson, J. Deanna;South-Paul, Jeannette E.
- 通讯作者:South-Paul, Jeannette E.
Opioid-Related Disparities in Sexual Minority Youth, 2017.
- DOI:10.1097/adm.0000000000000628
- 发表时间:2020-12
- 期刊:
- 影响因子:5.5
- 作者:Wilson JD;Sumetsky NM;Coulter RWS;Liebschutz J;Miller E;Mair CF
- 通讯作者:Mair CF
Implementation Science to Address Health Disparities During the Coronavirus Pandemic.
- DOI:10.1089/heq.2020.0044
- 发表时间:2020
- 期刊:
- 影响因子:2.7
- 作者:Galaviz KI;Breland JY;Sanders M;Breathett K;Cerezo A;Gil O;Hollier JM;Marshall C;Wilson JD;Essien UR
- 通讯作者:Essien UR
Trajectories of Opioid Use Following First Opioid Prescription in Opioid-Naive Youths and Young Adults.
- DOI:10.1001/jamanetworkopen.2021.4552
- 发表时间:2021-04-01
- 期刊:
- 影响因子:13.8
- 作者:Wilson JD;Abebe KZ;Kraemer K;Liebschutz J;Merlin J;Miller E;Kelley D;Donohue J
- 通讯作者:Donohue J
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jacqueline Deanna Wilson其他文献
Jacqueline Deanna Wilson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jacqueline Deanna Wilson', 18)}}的其他基金
Teaching harm reduction in vulnerable environments (THRIVE): a peer-led intervention bridging acute care settings and the discharge to the community
教导在脆弱环境中减少伤害(THRIVE):由同伴主导的干预措施,将急症护理环境与出院到社区联系起来
- 批准号:
10589388 - 财政年份:2022
- 资助金额:
$ 18.27万 - 项目类别:
Teaching harm reduction in vulnerable environments (THRIVE): a peer-led intervention bridging acute care settings and the discharge to the community
教导在脆弱环境中减少伤害(THRIVE):由同伴主导的干预措施,将急症护理环境与出院到社区联系起来
- 批准号:
10834851 - 财政年份:2022
- 资助金额:
$ 18.27万 - 项目类别:
Treatment of Opioid Use Disorder in Young Adults Hospitalized with Infectious Complications of Injection Opioid Use
因注射阿片类药物使用引起感染性并发症而住院的年轻人阿片类药物使用障碍的治疗
- 批准号:
10053965 - 财政年份:2020
- 资助金额:
$ 18.27万 - 项目类别:
Treatment of Opioid Use Disorder in Young Adults Hospitalized with Infectious Complications of Injection Opioid Use
因注射阿片类药物使用引起感染性并发症而住院的年轻人阿片类药物使用障碍的治疗
- 批准号:
10424528 - 财政年份:2020
- 资助金额:
$ 18.27万 - 项目类别:
Treatment of Opioid Use Disorder in Young Adults Hospitalized with Infectious Complications of Injection Opioid Use
因注射阿片类药物使用引起感染性并发症而住院的年轻人阿片类药物使用障碍的治疗
- 批准号:
10197083 - 财政年份:2020
- 资助金额:
$ 18.27万 - 项目类别:
相似海外基金
Studies on the Treatment of Opioid Use Disorder in Pregnancy
妊娠期阿片类药物使用障碍的治疗研究
- 批准号:
489082 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:
Operating Grants
Impact of Medicaid Prescription Cap Policies on Treatment Outcomes for Opioid Use Disorder: A National Mixed Methods Study
医疗补助处方上限政策对阿片类药物使用障碍治疗结果的影响:一项国家混合方法研究
- 批准号:
10637024 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:
Reducing Opioid and Other Drug Use in Justice-Involved Emerging Adults using Paraprofessional Coaches (with and without Lived Experience) to Deliver Effective Services in a Non-Treatment Setting
使用辅助专业教练(有或没有生活经验)减少涉及司法的新兴成年人的阿片类药物和其他药物使用,以在非治疗环境中提供有效的服务
- 批准号:
10846139 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:
HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On
HEAL 计划:促进患者可以信赖的阿片类药物使用障碍治疗系统的研究
- 批准号:
10772818 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:
Sleep and circadian rhythm phenotypes and mechanisms associated with opioid use disorder treatment outcomes
睡眠和昼夜节律表型以及与阿片类药物使用障碍治疗结果相关的机制
- 批准号:
10776106 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:
Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC
将接受阿片类药物使用障碍治疗且吸烟的个体转至 SREC
- 批准号:
10661301 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:
Development of an mHealth Behavioral Sleep Medicine Intervention for use during Medication Assisted Treatment for Opioid Use Disorder
开发用于阿片类药物使用障碍药物辅助治疗的 mHealth 行为睡眠医学干预措施
- 批准号:
10681901 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:
Development of an Opioid Sparing Therapeutic to Minimize Opioid Use Disorderand Tolerance in the Treatment of Pain
开发阿片类药物节约疗法,以最大限度地减少阿片类药物使用障碍和疼痛治疗耐受性
- 批准号:
10760487 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:
Medications for opioid use disorder differentially modulate intrinsically photosensitive retinal ganglion cell function, sleep, and circadian rhythms: implications for treatment
治疗阿片类药物使用障碍的药物差异调节本质光敏性视网膜神经节细胞功能、睡眠和昼夜节律:对治疗的影响
- 批准号:
10783274 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:
Disclosure Intervention to Reduce Social Isolation and Facilitate Recovery among People in Treatment for Opioid Use Disorder
披露干预措施,以减少阿片类药物使用障碍治疗人群的社会孤立并促进康复
- 批准号:
10780273 - 财政年份:2023
- 资助金额:
$ 18.27万 - 项目类别:














{{item.name}}会员




